Wilson Sonsini Goodrich & Rosati advised ALX Oncology Holdings Inc. on the deal. ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company developing therapies to block the…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
